SANUWAVE Health, Inc.
SNWV
$15.14
$0.231.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 22.52% | 34.96% | 40.86% | 57.39% | 61.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.52% | 34.96% | 40.86% | 57.39% | 61.46% |
| Cost of Revenue | 21.92% | 24.72% | 12.78% | 23.53% | 33.05% |
| Gross Profit | 22.70% | 38.33% | 51.33% | 70.84% | 72.72% |
| SG&A Expenses | 35.64% | 38.57% | 92.83% | 91.73% | 80.69% |
| Depreciation & Amortization | 16.90% | 11.53% | 6.87% | 7.45% | 7.25% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.17% | 37.73% | 74.16% | 77.45% | 74.79% |
| Operating Income | -37.45% | 5.84% | 88.61% | 445.24% | 1,961.95% |
| Income Before Tax | 146.57% | 134.66% | -2,281.82% | -1,071.30% | -100.83% |
| Income Tax Expenses | 218.52% | 218.52% | 575.00% | 575.00% | 575.00% |
| Earnings from Continuing Operations | 146.29% | 134.37% | -2,264.27% | -1,070.72% | -100.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 146.29% | 134.37% | -2,264.27% | -1,070.72% | -100.94% |
| EBIT | -37.45% | 5.84% | 88.61% | 445.24% | 1,961.95% |
| EBITDA | -29.49% | 9.22% | 78.66% | 278.06% | 603.25% |
| EPS Basic | 127.39% | 117.47% | -611.56% | -170.41% | 31.69% |
| Normalized Basic EPS | 120.93% | 114.93% | -179.04% | -128.12% | -9.36% |
| EPS Diluted | 104.52% | 97.15% | -1,862.74% | -150.21% | 28.53% |
| Normalized Diluted EPS | 119.97% | 114.06% | -171.53% | -125.59% | -9.95% |
| Average Basic Shares Outstanding | 47.20% | 91.89% | 174.15% | 146.81% | 132.25% |
| Average Diluted Shares Outstanding | 49.69% | 93.78% | 171.66% | 140.71% | 137.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |